JP2019043937A5 - - Google Patents

Download PDF

Info

Publication number
JP2019043937A5
JP2019043937A5 JP2018137952A JP2018137952A JP2019043937A5 JP 2019043937 A5 JP2019043937 A5 JP 2019043937A5 JP 2018137952 A JP2018137952 A JP 2018137952A JP 2018137952 A JP2018137952 A JP 2018137952A JP 2019043937 A5 JP2019043937 A5 JP 2019043937A5
Authority
JP
Japan
Prior art keywords
influenza
split vaccine
stem region
lah
binds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018137952A
Other languages
English (en)
Japanese (ja)
Other versions
JP7403733B2 (ja
JP2019043937A (ja
Filing date
Publication date
Application filed filed Critical
Priority to CN201880070955.0A priority Critical patent/CN111372605B/zh
Priority to MYPI2020001089A priority patent/MY204177A/en
Priority to EA202090587A priority patent/EA202090587A1/ru
Priority to EP18852584.4A priority patent/EP3679948A4/en
Priority to KR1020207009033A priority patent/KR102733152B1/ko
Priority to PCT/JP2018/032537 priority patent/WO2019045090A1/ja
Priority to CA3074581A priority patent/CA3074581A1/en
Priority to AU2018325899A priority patent/AU2018325899B2/en
Priority to SG11202001937TA priority patent/SG11202001937TA/en
Priority to US16/292,065 priority patent/US11732031B2/en
Publication of JP2019043937A publication Critical patent/JP2019043937A/ja
Priority to PH12020500414A priority patent/PH12020500414A1/en
Publication of JP2019043937A5 publication Critical patent/JP2019043937A5/ja
Priority to US18/341,960 priority patent/US20230406910A1/en
Application granted granted Critical
Publication of JP7403733B2 publication Critical patent/JP7403733B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018137952A 2017-09-04 2018-07-23 インフルエンザｈａスプリットワクチンの製造方法 Active JP7403733B2 (ja)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SG11202001937TA SG11202001937TA (en) 2017-09-04 2018-09-03 Method for producing influenza ha split vaccine
EA202090587A EA202090587A1 (ru) 2017-09-04 2018-09-03 Способ получения сплит-вакцины с на гриппа
EP18852584.4A EP3679948A4 (en) 2017-09-04 2018-09-03 METHOD OF MANUFACTURING INFLUENZA-HA-SPLIT VACCINE
KR1020207009033A KR102733152B1 (ko) 2017-09-04 2018-09-03 인플루엔자 ha 스플릿 백신의 제조 방법
PCT/JP2018/032537 WO2019045090A1 (ja) 2017-09-04 2018-09-03 インフルエンザｈａスプリットワクチンの製造方法
CA3074581A CA3074581A1 (en) 2017-09-04 2018-09-03 Method for producing influenza ha split vaccine
CN201880070955.0A CN111372605B (zh) 2017-09-04 2018-09-03 用于产生流感ha裂解疫苗的方法
MYPI2020001089A MY204177A (en) 2017-09-04 2018-09-03 Method for producing influenza ha split vaccine
AU2018325899A AU2018325899B2 (en) 2017-09-04 2018-09-03 Method for producing influenza HA split vaccine
US16/292,065 US11732031B2 (en) 2017-09-04 2019-03-04 Method for producing influenza HA split vaccine
PH12020500414A PH12020500414A1 (en) 2017-09-04 2020-03-02 Method for producing influenza ha split vaccine
US18/341,960 US20230406910A1 (en) 2017-09-04 2023-06-27 Method for producing influenza ha split vaccine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017169230 2017-09-04
JP2017169230 2017-09-04

Publications (3)

Publication Number Publication Date
JP2019043937A JP2019043937A (ja) 2019-03-22
JP2019043937A5 true JP2019043937A5 (enExample) 2021-09-02
JP7403733B2 JP7403733B2 (ja) 2023-12-25

Family

ID=65815411

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018137952A Active JP7403733B2 (ja) 2017-09-04 2018-07-23 インフルエンザｈａスプリットワクチンの製造方法

Country Status (10)

Country Link
US (1) US11732031B2 (enExample)
EP (1) EP3679948A4 (enExample)
JP (1) JP7403733B2 (enExample)
KR (1) KR102733152B1 (enExample)
CN (1) CN111372605B (enExample)
AU (1) AU2018325899B2 (enExample)
CA (1) CA3074581A1 (enExample)
EA (1) EA202090587A1 (enExample)
PH (1) PH12020500414A1 (enExample)
SG (1) SG11202001937TA (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7403733B2 (ja) 2017-09-04 2023-12-25 国立感染症研究所長 インフルエンザｈａスプリットワクチンの製造方法
US12059462B2 (en) 2018-07-23 2024-08-13 Japan As Represented By Director General Of National Institute Of Infectious Diseases Composition containing influenza vaccine
CA3132578A1 (en) 2019-03-04 2020-09-10 Japan As Represented By Director General Of National Institute Of Infectious Diseases Method for producing influenza ha split vaccine
EP4054630A2 (en) * 2019-11-07 2022-09-14 Seqirus UK Limited Compositions and methods for producing a viral vaccine with reduced particle size

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8278083B2 (en) 2004-03-22 2012-10-02 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Inactivated influenza virus compositions
US8044056B2 (en) 2007-03-20 2011-10-25 Dainippon Sumitomo Pharma Co., Ltd. Adenine compound
BRPI0911699B8 (pt) 2008-07-25 2023-02-28 Inst Res Biomedicine vetor, célula, composição farmacêutica, uso de um anticorpo, ou fragmento de ligação a antígeno deste
WO2010047509A2 (ko) 2008-10-24 2010-04-29 아주대학교 산학협력단 친화도와 안정성이 향상된 항 ｄｒ5 항체, 및 이를 포함하는 암 예방 또는 치료용 조성물
CN101524538A (zh) * 2009-03-26 2009-09-09 成都康华生物制品有限公司 一种流感-大流行流感二价联合疫苗及其制备方法
MX338758B (es) 2010-03-08 2016-04-29 Celltrion Inc Anticuerpos monoclonales humanos, derivados de celulas b humanas, y que tienen actividad neutralizante contra el virus de la influenza a.
AU2011235220B2 (en) 2010-03-30 2016-03-10 Mount Sinai School Of Medicine Influenza virus vaccines and uses thereof
KR101960928B1 (ko) 2011-04-21 2019-07-17 올로지 바이오서비시즈, 인크. 백신으로부터 항원을 단리하고 정량하기 위한 방법
US20150098966A1 (en) * 2012-05-16 2015-04-09 Kj Biosciences Llc Influenza vaccines
KR20140118682A (ko) 2013-03-29 2014-10-08 (주)셀트리온 2 이상의 인플루엔자 ａ 바이러스 중화 결합 분자를 포함하는 조성물
CN106794241A (zh) * 2014-08-18 2017-05-31 圣诺菲·帕斯图尔公司 烷基化流感疫苗
SG11201705264WA (en) 2014-12-31 2017-07-28 The Usa As Represented By The Secretary Detp Of Health And Human Services Novel multivalent nanoparticle-based vaccines
JP7403733B2 (ja) 2017-09-04 2023-12-25 国立感染症研究所長 インフルエンザｈａスプリットワクチンの製造方法
US12059462B2 (en) 2018-07-23 2024-08-13 Japan As Represented By Director General Of National Institute Of Infectious Diseases Composition containing influenza vaccine

Similar Documents

Publication Publication Date Title
MX2014000749A (es) Anticuerpos neutralizantes del virus de la influenza a y usos de estos.
JP2019043937A5 (enExample)
CY1123462T1 (el) Αντισωματα που εξουδετερωνουν ισχυρα τον ιο ηπατιτιδας β και χρησεις αυτων
CL2021002994A1 (es) Anticuerpos nuevos que se unen específicamente a los epítopos del virus del zika y usos de los mismos. (divisional de la solicitud no. 201900067)
MX389274B (es) Anticuerpo que neutraliza el virus respiratorio sincitial humano.
MX2011000767A (es) Anticuerpos neutralizantes del virus anti-influenza a y usos de los mismos.
MX385818B (es) Proteínas f de rsv de prefusión y su uso.
MX2021006756A (es) Anticuerpos que neutralizan el virus de la hepatitis b y usos de los mismos.
CN103562403A8 (zh) 识别肿瘤起始细胞的抗体和抗原及其应用
JP2017200489A5 (enExample)
JP2014237714A5 (enExample)
JP2016503413A5 (enExample)
MX2022005498A (es) Vacuna del zika/dengue y aplicación de la misma.
EA202090587A1 (ru) Способ получения сплит-вакцины с на гриппа
EA201300130A1 (ru) Способ лечения болезни альцгеймера
AR087749A1 (es) Anticuerpos anti-xcr1 humano
WO2015120097A3 (en) Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
EA202192398A1 (ru) Способ приготовления сплит-вакцины против гриппа на основе гемагглютинина
CA2839668C (en) Epitope and its use of hepatitis b virus surface antigen
WO2017053525A3 (en) Influenza vaccine and therapy
CN109890843A (zh) 一种abcg2单克隆抗体及其用途
WO2015143194A3 (en) Immunogenetic restriction on elicitation of antibodies
MY204177A (en) Method for producing influenza ha split vaccine
TH2001001236A (th) วิธีการผลิตสพลิทวัคซีนชนิด ha สำหรับไข้หวัดใหญ่
MX2017014146A (es) Glicoproteína de hemaglutinina h7 modificada de la secuencia de influenza a/shanghai/2/2013 h7.